COVID-19: breaking down a global health crisis
Abstract Coronavirus disease 2019 (COVID-19) is the second pandemic of the twenty-first
century, with over one-hundred million infections and over two million deaths to date. It is a …
century, with over one-hundred million infections and over two million deaths to date. It is a …
COVID-19 vaccines: The status and perspectives in delivery points of view
Due to the high prevalence and long incubation periods often without symptoms, the severe
acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has infected millions of individuals …
acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has infected millions of individuals …
[HTML][HTML] COVID-19-neutralizing antibodies predict disease severity and survival
WF Garcia-Beltran, EC Lam, MG Astudillo, D Yang… - Cell, 2021 - cell.com
Summary Coronavirus disease 2019 (COVID-19) exhibits variable symptom severity ranging
from asymptomatic to life-threatening, yet the relationship between severity and the humoral …
from asymptomatic to life-threatening, yet the relationship between severity and the humoral …
[HTML][HTML] COVID-19 in early 2021: current status and looking forward
C Wang, Z Wang, G Wang, JYN Lau… - Signal Transduction and …, 2021 - nature.com
Since the first description of a coronavirus-related pneumonia outbreak in December 2019,
the virus SARS-CoV-2 that causes the infection/disease (COVID-19) has evolved into a …
the virus SARS-CoV-2 that causes the infection/disease (COVID-19) has evolved into a …
COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives
Abstract Coronavirus disease 2019 (COVID-19), caused by a strain of coronavirus known as
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global …
Angiotensin‐converting enzyme 2 (ACE2), SARS‐CoV‐2 and the pathophysiology of coronavirus disease 2019 (COVID‐19)
AR Bourgonje, AE Abdulle, W Timens… - The Journal of …, 2020 - Wiley Online Library
Abstract Angiotensin‐converting enzyme 2 (ACE2) has been established as the functional
host receptor for severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the virus …
host receptor for severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the virus …
[HTML][HTML] Immune response in COVID-19: A review
The immune system protects us from viruses and diseases. It produces an antibody to kill
pathogen. This review shows a brief picture about the immune system to protect us from …
pathogen. This review shows a brief picture about the immune system to protect us from …
Infectious Diseases Society of America Guidelines on the treatment and management of patients with coronavirus disease 2019 (COVID-19)
Background There are many pharmacologic therapies that are being used or considered for
treatment of coronavirus disease 2019 (COVID-19). There is a need for frequently updated …
treatment of coronavirus disease 2019 (COVID-19). There is a need for frequently updated …
The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from …
MC Grant, L Geoghegan, M Arbyn, Z Mohammed… - PloS one, 2020 - journals.plos.org
Background To limit the spread of SARS-CoV-2, an evidence-based understanding of the
symptoms is critical to inform guidelines for quarantining and testing. The most common …
symptoms is critical to inform guidelines for quarantining and testing. The most common …
Drug treatments for covid-19: living systematic review and network meta-analysis
Objective To compare the effects of treatments for coronavirus disease 2019 (covid-19).
Design Living systematic review and network meta-analysis. Data sources WHO covid-19 …
Design Living systematic review and network meta-analysis. Data sources WHO covid-19 …